Integra Lifesciences Announces CEO Transition and New Executive Chairman
Company Announcements

Integra Lifesciences Announces CEO Transition and New Executive Chairman

The latest announcement is out from Integra Lifesciences Holdings Corp. (IART).

Jan De Witte plans to retire from his role as President and CEO of Integra LifeSciences, but will remain in his current position until a successor is appointed to ensure a smooth leadership transition. He has entered into a consulting agreement to advise the new CEO post-retirement. Meanwhile, Stuart M. Essig has been named Executive Chairman. De Witte’s retirement is due to personal reasons and not because of any disagreement with the company’s operations or policies.

Find detailed analytics on IART stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyIntegra LifeSciences price target raised to $26 from $21 at Truist
TheFlyIntegra LifeSciences price target raised to $22 from $16 at Citi
TipRanks Auto-Generated NewsdeskIntegra LifeSciences Announces Q3 2024 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App